Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice

Jacqueline G. Parchem, Keizo Kanasaki, Megumi Kanasaki, Hikaru Sugimoto, Liang Xie, Yuki Hamano, Soo Bong Lee, Vincent H. Gattone, Samuel Parry, Jerome F. Strauss, Vesna D. Garovic, Thomas F. McElrath, Karen H. Lu, Baha M. Sibai, Valerie S. LeBleu, Peter Carmeliet, Raghu Kalluri

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Preeclampsia remains a clinical challenge due to its poorly understood pathogenesis. A prevailing notion is that increased placental production of soluble fms-like tyrosine kinase-1 (sFlt-1) causes the maternal syndrome by inhibiting proangiogenic placental growth factor (PlGF) and VEGF. However, the significance of PlGF suppression in preeclampsia is uncertain. To test whether preeclampsia results from the imbalance of angiogenic factors reflected by an abnormal sFlt-1/PlGF ratio, we studied PlGF KO (Pgf-/-) mice and noted that the mice did not develop signs or sequelae of preeclampsia despite a marked elevation in circulating sFLT-1. Notably, PlGF KO mice had morphologically distinct placentas, showing an accumulation of junctional zone glycogen. We next considered the role of placental PlGF in an established model of preeclampsia (pregnant catechol-O-methyltransferase-deficient [COMT-deficient] mice) by generating mice with deletions in both the Pgf and Comt genes. Deletion of placental PlGF in the context of COMT loss resulted in a reduction in maternal blood pressure and increased placental glycogen, indicating that loss of PlGF might be protective against the development of preeclampsia. These results identify a role for PlGF in placental development and support a complex model for the pathogenesis of preeclampsia beyond an angiogenic factor imbalance.

Original languageEnglish (US)
Pages (from-to)5008-5017
Number of pages10
JournalJournal of Clinical Investigation
Volume128
Issue number11
DOIs
StatePublished - Nov 1 2018

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice'. Together they form a unique fingerprint.

  • Cite this

    Parchem, J. G., Kanasaki, K., Kanasaki, M., Sugimoto, H., Xie, L., Hamano, Y., Lee, S. B., Gattone, V. H., Parry, S., Strauss, J. F., Garovic, V. D., McElrath, T. F., Lu, K. H., Sibai, B. M., LeBleu, V. S., Carmeliet, P., & Kalluri, R. (2018). Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice. Journal of Clinical Investigation, 128(11), 5008-5017. https://doi.org/10.1172/JCI99026